🌱 Longevity & Cardiovascular 🔵 Advanced

Homocysteine

An amino acid byproduct that builds up when methylation pathways aren't working well , elevated levels are linked to cardiovascular and cognitive risk.

What is Plasma Homocysteine?

Homocysteine is a sulfur-containing amino acid produced as a normal intermediate in methionine metabolism , the process by which cells use the essential amino acid methionine (abundant in meat, eggs, and dairy) to perform biochemical functions. Under healthy conditions, homocysteine is cleared from the bloodstream through two pathways: remethylation (converting it back to methionine using folate and vitamin B12 as cofactors) and transsulfuration (converting it to the antioxidant cysteine using vitamin B6). When either pathway is impaired , due to B12, folate, or B6 deficiency, MTHFR gene variants, kidney dysfunction, or excessive protein intake relative to B-vitamin status , homocysteine accumulates in the blood.

Elevated plasma homocysteine is an established independent risk factor for cardiovascular disease, stroke, and all-cause mortality in epidemiological research. More recently, it has emerged as one of the strongest modifiable nutritional risk factors for cognitive decline and dementia , elevated homocysteine causes direct vascular and neurotoxic effects on brain tissue, accelerating the neurodegeneration pathways that cognitive decline research aims to address. The key distinguishing feature of homocysteine as a risk factor is that it is directly correctable: B12, folate, and B6 supplementation can meaningfully reduce homocysteine in most individuals.

What do the numbers mean?

Optimal (functional target)
Under 8 µmol/L
Functional medicine and longevity research target. Values in this range suggest healthy methylation pathway activity and minimal homocysteine-associated vascular and neural stress.
Standard Normal
Under 15 µmol/L
Standard lab cutoff for normal range. Values between 10–15 µmol/L are technically "normal" but are associated with meaningfully increased cardiovascular and cognitive risk in research literature.
Out of Range , Note
15–30 µmol/L moderate
Above 30 µmol/L severe
15–30 µmol/L = moderate hyperhomocysteinemia, associated with substantially elevated cardiovascular and cognitive risk. Above 30 µmol/L = severe and warrants immediate clinical evaluation and intervention.

Even values above 10 µmol/L are associated with increased risk in research literature , the "normal" cutoff of 15 µmol/L is a statistical threshold, not an absence of concern. Active B12 or folate supplementation can acutely lower homocysteine; note any supplementation when testing for a true baseline reading.

Why this marker matters before peptide research.

Homocysteine is a methylation health marker , and methylation is the biochemical process that underlies DNA regulation, neurotransmitter synthesis, epigenetic aging, and cellular repair. In longevity peptide research, high homocysteine is a signal that methylation pathways are under stress, which has downstream consequences for the very cellular mechanisms that longevity compounds like NAD+, Epithalon, and MOTS-c are proposed to support. Researching cellular aging compounds on a foundation of impaired methylation is working against the biology the compounds are intended to support.

For cognitive peptide research, homocysteine is particularly critical. The research linking elevated homocysteine to cognitive decline and dementia risk is among the most robust in nutritional neuroscience , large prospective studies show that individuals in the highest quartile of homocysteine have double to triple the risk of Alzheimer's disease compared to those in the lowest quartile. This is not a subtle association. Before researching cognitive peptides like Semax, Selank, Dihexa, or NAD+ for cognitive enhancement purposes, establishing that homocysteine is in the optimal range ensures the research is conducted from a neurological baseline that is not being undermined by an addressable nutritional insufficiency.

The actionability of homocysteine is one of its most important features in a research context. Unlike many biomarkers that reflect structural or genetic factors not easily modified, elevated homocysteine in most individuals responds to B12, folate, and B6 repletion within 4–8 weeks. This means a researcher who identifies elevated homocysteine has a clear, direct, low-cost foundational step to take before initiating any cognitive or longevity peptide protocol , improving the baseline before the protocol begins rather than trying to compensate for it with more complex interventions.

How to get this test.

Where to order

Standard blood draw at LabCorp, Quest Diagnostics, or through a physician. Not included in most standard panels , must be requested specifically. Available via some direct-to-consumer longevity and cardiovascular panels without a prescription.

How to prepare

Fasting preferred (8–12 hours) for the most consistent results. Note any B12, folate, or B6 supplementation on the lab requisition , these directly lower homocysteine and will mask a true baseline if taken within days of the draw.

What to ask for

"Plasma Homocysteine" or "Homocysteine." Order alongside B12 and folate for complete methylation pathway context. Adding hs-CRP and ApoB creates a comprehensive cardiovascular and longevity risk baseline in a single draw session.

Peptides commonly researched in connection with this marker.

NAD+ NAD+ supports sirtuin-mediated DNA repair and epigenetic maintenance , processes that depend on healthy methylation. Elevated homocysteine signals impaired methylation that warrants addressing as a foundational step before NAD+ longevity research.
Epithalon Epithalon's proposed telomere-protective and epigenetic effects operate in the same methylation-dependent cellular environment that homocysteine impairs , baseline homocysteine is part of the comprehensive biological aging assessment before longevity research.
MOTS-c Mitochondrial-derived peptide studied in metabolic and aging contexts , homocysteine is part of the longevity baseline panel alongside DHEA-S, ApoB, and hs-CRP that contextualizes biological aging rate before any mitochondria-targeting protocol.
Semax Cognitive peptide research requires ruling out modifiable neurological risk factors before attributing outcomes to the compound. Elevated homocysteine is one of the most significant nutritional drivers of cognitive impairment , it must be addressed before cognitive enhancement research begins.
Selank Homocysteine-mediated neuroinflammation contributes to anxiety and mood dysregulation , the same targets Selank research addresses. Optimal methylation status establishes a cleaner baseline for interpreting anxiolytic and stress-modulating peptide research outcomes.
SS-31 Mitochondria-targeted peptide studied in aging and cellular energy contexts , homocysteine is part of the advanced longevity panel that establishes the full systemic aging context before initiating any cellular-level anti-aging research protocol.

Goals where this biomarker is most relevant.

Ready to build your baseline?

Use Pepvela's Lab Guide to understand which markers to test first, then use the Peptide Finder to match your biology to research-relevant compounds.

For educational and research purposes only. Not medical advice. Always consult a licensed healthcare provider before making any health decisions.